| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.08e-09 | 4 | 116 | 4 | GO:0004971 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.04e-09 | 27 | 116 | 6 | GO:0008066 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.55e-08 | 17 | 116 | 5 | GO:0004970 | |
| GeneOntologyMolecularFunction | protein kinase activity | TRIB2 EPHA6 ERN1 PPM1D CDK11A ALPK1 NEK9 PRKD3 STK3 PHKA1 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 6.85e-08 | 600 | 116 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | JUN kinase activity | 1.91e-07 | 3 | 116 | 3 | GO:0004705 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.36e-07 | 24 | 116 | 5 | GO:0099507 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRIB2 EPHA6 ERN1 PPM1D CDK11A ALPK1 NEK9 PRKD3 STK3 PHKA1 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 7.19e-07 | 709 | 116 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRIB2 EPHA6 ERN1 PPM1D CDK11A ALPK1 CMAS NEK9 PRKD3 STK3 PHKA1 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 REV1 | 1.88e-06 | 938 | 116 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ERN1 PPM1D CDK11A ALPK1 NEK9 PRKD3 STK3 PHKA1 NEK2 MAPK8 MAPK9 MAPK10 STK24 | 1.97e-06 | 446 | 116 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase activity | TRIB2 EPHA6 ERN1 PPM1D CDK11A ALPK1 NEK9 PRKD3 STK3 PHKA1 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 1.99e-06 | 764 | 116 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.18e-06 | 102 | 116 | 7 | GO:0001540 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B SCN11A TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG PKD2 CACNA1G KCNT1 | 2.71e-06 | 459 | 116 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B SCN11A TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 3.53e-06 | 627 | 116 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.90e-06 | 75 | 116 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B SCN11A TRPC4 GRIA1 GRIA2 GRIA3 GRIN2D ATP5MG PKD2 CACNA1G KCNT1 | 5.16e-06 | 343 | 116 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B SCN11A SLC37A3 TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 8.00e-06 | 758 | 116 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | protein serine kinase activity | ERN1 CDK11A ALPK1 NEK9 PRKD3 STK3 NEK2 MAPK8 MAPK9 MAPK10 STK24 | 8.82e-06 | 363 | 116 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.04e-05 | 129 | 116 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.05e-05 | 8 | 116 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1B SCN11A TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG PKD2 CACNA1G KCNT1 | 1.15e-05 | 525 | 116 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B SCN11A TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG PKD2 CACNA1G KCNT1 | 1.18e-05 | 526 | 116 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B SCN11A TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 1.40e-05 | 793 | 116 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B SCN11A TRPC4 GRIA1 GRIA2 GRIA3 GRIN2D SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 1.70e-05 | 465 | 116 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.00e-05 | 57 | 116 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B GRIA1 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D PKD2 CACNA1G KCNT1 | 2.55e-05 | 334 | 116 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.57e-05 | 60 | 116 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.58e-05 | 100 | 116 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.88e-05 | 151 | 116 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.01e-05 | 31 | 116 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B SCN11A TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 3.13e-05 | 664 | 116 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.79e-05 | 65 | 116 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.79e-05 | 65 | 116 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 8.59e-05 | 77 | 116 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.01e-04 | 16 | 116 | 3 | GO:0004707 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.36e-04 | 193 | 116 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.54e-04 | 197 | 116 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.68e-04 | 140 | 116 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.99e-04 | 4 | 116 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.36e-04 | 52 | 116 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.16e-04 | 293 | 116 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | amide binding | 3.61e-04 | 299 | 116 | 8 | GO:0033218 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.69e-04 | 105 | 116 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.51e-04 | 26 | 116 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B SCN11A SLC37A3 TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 4.62e-04 | 1180 | 116 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.93e-04 | 171 | 116 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | protein kinase binding | TRIB2 PPM1D GRIA1 GRIA2 PTPN22 SPG11 CNTLN GRM5 NEK9 RIMS1 MAPK8 MAPK9 TRIB1 DNM2 | 5.41e-04 | 873 | 116 | 14 | GO:0019901 |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 5.63e-04 | 28 | 116 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 9.16e-04 | 8 | 116 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | adenosine receptor binding | 9.16e-04 | 8 | 116 | 2 | GO:0031685 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1B SCN11A SLC37A3 TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 TMC4 GRIN2D ATP5MG SLC22A1 PKD2 CACNA1G SLC5A12 KCNT1 | 1.24e-03 | 1289 | 116 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.33e-03 | 207 | 116 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.36e-03 | 208 | 116 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.47e-03 | 211 | 116 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | kinase binding | TRIB2 PPM1D GRIA1 GRIA2 PTPN22 SPG11 CNTLN GRM5 NEK9 RIMS1 MAPK8 MAPK9 TRIB1 DNM2 | 1.48e-03 | 969 | 116 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.95e-03 | 152 | 116 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.42e-03 | 46 | 116 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 2.57e-03 | 47 | 116 | 3 | GO:0004712 | |
| GeneOntologyMolecularFunction | peptide binding | 2.58e-03 | 318 | 116 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 2.90e-03 | 49 | 116 | 3 | GO:0048487 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.91e-03 | 14 | 116 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | EED TRIB2 FN1 SWAP70 BCAS3 STXBP5 LARS1 COX15 GRM5 NEK9 STK3 BTK RIMS1 MAPK8 MAPK9 CABIN1 TRIB1 | 3.37e-03 | 1418 | 116 | 17 | GO:0030234 |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 3.81e-03 | 16 | 116 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.23e-03 | 182 | 116 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 4.42e-03 | 114 | 116 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.43e-03 | 184 | 116 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 4.92e-03 | 656 | 116 | 10 | GO:0008047 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 5.36e-03 | 19 | 116 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 5.94e-03 | 124 | 116 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 6.76e-03 | 288 | 116 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 7.16e-03 | 22 | 116 | 2 | GO:0046527 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.52e-08 | 59 | 114 | 7 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 6.20e-08 | 180 | 114 | 10 | GO:0060078 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 3.46e-07 | 27 | 114 | 5 | GO:0035235 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 RIMS1 MAPK8 MAPK9 RIMS2 | 7.51e-07 | 663 | 114 | 16 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 RIMS1 MAPK8 MAPK9 RIMS2 | 7.66e-07 | 664 | 114 | 16 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | AKAP6 SCN11A RELN TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 CACNA1G RIMS1 RIMS2 KCNT1 | 2.55e-06 | 559 | 114 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 2.66e-06 | 40 | 114 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 CACNA1G RIMS1 MAPK8 MAPK9 RIMS2 DAGLA | 3.87e-06 | 939 | 114 | 18 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | AKAP6 CACNA1B SCN11A RELN TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 PTPN22 SPG11 TMC4 GRIN2D ATP5MG SLC22A1 PKD2 FGF11 CACNA1G SLC5A12 KCNT1 DNM2 | 5.40e-06 | 1374 | 114 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 5.66e-06 | 7 | 114 | 3 | GO:0150037 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 5.95e-06 | 233 | 114 | 9 | GO:0050806 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 CACNA1G RIMS1 MAPK8 MAPK9 RIMS2 DAGLA | 6.60e-06 | 976 | 114 | 18 | GO:0099536 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 8.73e-06 | 132 | 114 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | Fc-epsilon receptor signaling pathway | 1.02e-05 | 25 | 114 | 4 | GO:0038095 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | AKAP6 CACNA1B SCN11A RELN TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 PTPN22 TMC4 GRIN2D ATP5MG SLC22A1 PKD2 FGF11 CACNA1G KCNT1 | 1.10e-05 | 1115 | 114 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 CACNA1G RIMS1 MAPK8 MAPK9 RIMS2 | 1.40e-05 | 931 | 114 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1B RELN STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRIN2D ZDHHC17 GRM5 USP8 CACNA1G RIMS1 MAPK8 MAPK9 RIMS2 | 1.40e-05 | 931 | 114 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 2.82e-05 | 32 | 114 | 4 | GO:0099505 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 LIFR HMCN2 MACF1 RIMS1 MAPK8 RIMS2 DNM2 | 3.57e-05 | 802 | 114 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 4.52e-05 | 13 | 114 | 3 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 4.52e-05 | 13 | 114 | 3 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 4.52e-05 | 13 | 114 | 3 | GO:0099502 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 LIFR HMCN2 MACF1 RIMS1 MAPK8 RIMS2 DNM2 | 4.53e-05 | 819 | 114 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron development | SCN11A RELN FN1 TOX EPHA6 STXBP5 APBB2 SPG11 ZMIZ1 ZDHHC17 GBA2 LIFR HMCN2 DHFR2 MACF1 RIMS1 MAPK8 MAPK9 RIMS2 STK24 DNM2 | 4.66e-05 | 1463 | 114 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 LIFR HMCN2 MACF1 RIMS1 MAPK8 RIMS2 DNM2 | 4.99e-05 | 826 | 114 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 HMCN2 DHFR2 MACF1 STK24 DNM2 | 5.53e-05 | 642 | 114 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection development | SCN11A RELN FN1 TOX EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 LIFR HMCN2 DHFR2 MACF1 RIMS1 MAPK8 MAPK9 RIMS2 STK24 DNM2 | 7.64e-05 | 1285 | 114 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 9.25e-05 | 43 | 114 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.58e-04 | 92 | 114 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1.75e-04 | 20 | 114 | 3 | GO:0031630 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle membrane organization | 1.75e-04 | 20 | 114 | 3 | GO:1901632 | |
| GeneOntologyBiologicalProcess | positive regulation of vesicle fusion | 1.75e-04 | 20 | 114 | 3 | GO:0031340 | |
| GeneOntologyBiologicalProcess | protein localization to tricellular tight junction | 1.80e-04 | 4 | 114 | 2 | GO:0061833 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification by small protein conjugation or removal | 1.87e-04 | 150 | 114 | 6 | GO:1903322 | |
| GeneOntologyBiologicalProcess | positive regulation of post-translational protein modification | 1.94e-04 | 151 | 114 | 6 | GO:1901875 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | AKAP6 CACNA1B SCN11A TRPC4 COX15 GRIA2 PTPN22 SPG11 GRIN2D ATP5MG SLC22A1 PKD2 FGF11 CACNA1G SLC5A12 KCNT1 DNM2 | 2.05e-04 | 1157 | 114 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulated exocytosis | 2.16e-04 | 291 | 114 | 8 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 2.26e-04 | 293 | 114 | 8 | GO:0048167 | |
| GeneOntologyBiologicalProcess | dolichol-linked oligosaccharide biosynthetic process | 2.35e-04 | 22 | 114 | 3 | GO:0006488 | |
| GeneOntologyBiologicalProcess | regulation of protein ubiquitination | 2.63e-04 | 226 | 114 | 7 | GO:0031396 | |
| GeneOntologyBiologicalProcess | positive regulation of NLRP3 inflammasome complex assembly | 2.69e-04 | 23 | 114 | 3 | GO:1900227 | |
| GeneOntologyBiologicalProcess | axonogenesis | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 HMCN2 MACF1 DNM2 | 3.03e-04 | 566 | 114 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | centrosome cycle | 3.03e-04 | 164 | 114 | 6 | GO:0007098 | |
| GeneOntologyBiologicalProcess | dolichol metabolic process | 3.06e-04 | 24 | 114 | 3 | GO:0019348 | |
| GeneOntologyBiologicalProcess | exocytic process | 3.21e-04 | 107 | 114 | 5 | GO:0140029 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | AKAP6 MRC1 NUGGC ERN1 LARS1 GRIA1 GRIA2 PTPN22 GRIN2D GRM5 USP8 SCARB1 BTK DHFR2 PKD2 MAPK8 MAPK9 TRIB1 DNM2 | 3.62e-04 | 1450 | 114 | 19 | GO:1901701 |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 3.86e-04 | 62 | 114 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 3.90e-04 | 26 | 114 | 3 | GO:0141087 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 3.90e-04 | 26 | 114 | 3 | GO:0032693 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 4.62e-04 | 65 | 114 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | cellular response to reactive oxygen species | 4.69e-04 | 178 | 114 | 6 | GO:0034614 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 4.83e-04 | 179 | 114 | 6 | GO:0031023 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 5.41e-04 | 29 | 114 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal protein catabolic process | 6.08e-04 | 123 | 114 | 5 | GO:1901800 | |
| GeneOntologyBiologicalProcess | positive regulation of protein ubiquitination | 6.30e-04 | 124 | 114 | 5 | GO:0031398 | |
| GeneOntologyBiologicalProcess | synaptic vesicle fusion to presynaptic active zone membrane | 6.60e-04 | 31 | 114 | 3 | GO:0031629 | |
| GeneOntologyBiologicalProcess | regulation of receptor recycling | 6.60e-04 | 31 | 114 | 3 | GO:0001919 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 6.60e-04 | 31 | 114 | 3 | GO:0016082 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | AKAP6 CACNA1B SCN11A TRPC4 COX15 GRIA2 PTPN22 GRIN2D ATP5MG SLC22A1 PKD2 FGF11 CACNA1G KCNT1 | 6.97e-04 | 942 | 114 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 6.98e-04 | 266 | 114 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | vesicle fusion to plasma membrane | 7.26e-04 | 32 | 114 | 3 | GO:0099500 | |
| GeneOntologyBiologicalProcess | regulation of protein modification by small protein conjugation or removal | 7.79e-04 | 271 | 114 | 7 | GO:1903320 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 7.95e-04 | 75 | 114 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | JNK cascade | 8.19e-04 | 198 | 114 | 6 | GO:0007254 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 8.36e-04 | 76 | 114 | 4 | GO:0006487 | |
| GeneOntologyBiologicalProcess | regulation of post-translational protein modification | 8.85e-04 | 277 | 114 | 7 | GO:1901873 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SCN11A RELN FN1 EPHA6 STXBP5 APBB2 SPG11 ZDHHC17 HMCN2 MACF1 MAPK8 DNM2 | 8.89e-04 | 748 | 114 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of TOR signaling | 9.22e-04 | 78 | 114 | 4 | GO:0032008 | |
| GeneOntologyBiologicalProcess | regulation of vesicle fusion | 9.46e-04 | 35 | 114 | 3 | GO:0031338 | |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 9.67e-04 | 79 | 114 | 4 | GO:0062208 | |
| GeneOntologyBiologicalProcess | synaptic vesicle membrane organization | 1.03e-03 | 36 | 114 | 3 | GO:0048499 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.03e-03 | 207 | 114 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | glycoside catabolic process | 1.06e-03 | 9 | 114 | 2 | GO:0016139 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 1.11e-03 | 82 | 114 | 4 | GO:0017156 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 1.16e-03 | 142 | 114 | 5 | GO:0006906 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 1.23e-03 | 293 | 114 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 1.23e-03 | 144 | 114 | 5 | GO:0060291 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 1.23e-03 | 144 | 114 | 5 | GO:0090174 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.27e-03 | 85 | 114 | 4 | GO:0032436 | |
| GeneOntologyBiologicalProcess | cellular response to oxidative stress | 1.27e-03 | 295 | 114 | 7 | GO:0034599 | |
| GeneOntologyBiologicalProcess | heme A biosynthetic process | 1.32e-03 | 10 | 114 | 2 | GO:0006784 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 1.32e-03 | 10 | 114 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | heme a metabolic process | 1.32e-03 | 10 | 114 | 2 | GO:0046160 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | CACNA1B RELN FN1 TOX SWAP70 PTPN22 USP8 NEK2 PHLDB1 BTK MACF1 RIMS1 MAPK8 MAPK9 RIMS2 STK24 DNM2 | 1.34e-03 | 1366 | 114 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.35e-03 | 147 | 114 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | AKAP6 CACNA1B RELN TRPC4 PTPN22 SPG11 GRIN2D PKD2 FGF11 CACNA1G | 1.37e-03 | 577 | 114 | 10 | GO:0043269 |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis involved in protein catabolic process | 1.39e-03 | 148 | 114 | 5 | GO:1903052 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.43e-03 | 301 | 114 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.51e-03 | 392 | 114 | 8 | GO:0070588 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | AKAP6 CACNA1B SCN11A STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ATP5MG PKD2 CACNA1G | 1.67e-07 | 378 | 115 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | neuron to neuron synapse | STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 USP6 USP8 MACF1 RIMS1 MAPK10 DAGLA KCNT1 DNM2 | 1.86e-07 | 523 | 115 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 USP6 USP8 MACF1 RIMS1 MAPK10 DAGLA KCNT1 DNM2 | 1.89e-07 | 451 | 115 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 USP6 USP8 MACF1 RIMS1 MAPK10 DAGLA KCNT1 DNM2 | 3.73e-07 | 477 | 115 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 USP6 USP8 MACF1 RIMS1 MAPK10 DAGLA KCNT1 DNM2 | 7.03e-07 | 503 | 115 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.13e-06 | 141 | 115 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.54e-06 | 157 | 115 | 8 | GO:0098839 | |
| GeneOntologyCellularComponent | presynaptic membrane | SCN11A STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ZDHHC17 RIMS1 RIMS2 | 3.11e-06 | 277 | 115 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ZDHHC17 GRM5 RIMS1 RIMS2 DAGLA KCNT1 DNM2 | 3.95e-06 | 583 | 115 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 4.52e-06 | 78 | 115 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.73e-06 | 45 | 115 | 5 | GO:0008328 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | AKAP6 CACNA1B SCN11A STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ATP5MG PKD2 CACNA1G | 6.19e-06 | 523 | 115 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 8.03e-06 | 50 | 115 | 5 | GO:0098878 | |
| GeneOntologyCellularComponent | transporter complex | AKAP6 CACNA1B SCN11A STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ATP5MG PKD2 CACNA1G | 1.06e-05 | 550 | 115 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.56e-05 | 201 | 115 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 2.13e-05 | 30 | 115 | 4 | GO:0032281 | |
| GeneOntologyCellularComponent | axon | CACNA1B SCN11A RELN APBB2 HMBS GRIA1 GRIA2 GRIA3 GRIA4 SPG11 ARL8A HMCN2 ARL8B MAPK8 DAGLA DNM2 | 2.98e-05 | 891 | 115 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.99e-05 | 35 | 115 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1B SCN11A GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ZDHHC17 GRM5 USP6 USP8 RIMS1 MAPK10 RIMS2 DNM2 | 4.20e-05 | 817 | 115 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | cation channel complex | 4.77e-05 | 235 | 115 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | dendritic shaft | 5.50e-05 | 74 | 115 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | postsynaptic Golgi apparatus | 8.97e-05 | 3 | 115 | 2 | GO:0150051 | |
| GeneOntologyCellularComponent | cell cortex region | 1.09e-04 | 45 | 115 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.40e-04 | 48 | 115 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | postsynapse | SWAP70 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ZDHHC17 GRM5 USP6 USP8 MACF1 RIMS1 MAPK10 DAGLA KCNT1 DNM2 | 1.43e-04 | 1018 | 115 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | cytoplasmic region | 1.71e-04 | 360 | 115 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | perisynaptic space | 1.79e-04 | 4 | 115 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.18e-04 | 155 | 115 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | dendritic spine | 3.88e-04 | 242 | 115 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B SCN11A RELN EPHA6 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRM5 USP8 HMCN2 CACNA1G MAPK8 MAPK9 MAPK10 DAGLA | 3.91e-04 | 1228 | 115 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.06e-04 | 405 | 115 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | neuron spine | 4.38e-04 | 247 | 115 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | cell leading edge | 4.44e-04 | 500 | 115 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | membrane protein complex | AKAP6 CACNA1B SCN11A ERN1 STXBP5 TRPC4 GRIA1 COX15 GRIA2 GRIA3 GRIA4 GRIN2D STT3A ATP5MG CYCS PKD2 CACNA1G EMC2 IL23R | 5.14e-04 | 1498 | 115 | 19 | GO:0098796 |
| GeneOntologyCellularComponent | sodium channel complex | 5.34e-04 | 29 | 115 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | basal cortex | 6.19e-04 | 7 | 115 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | calcium channel complex | 7.06e-04 | 73 | 115 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 8.22e-04 | 8 | 115 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | dendrite | CACNA1B RELN EPHA6 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRM5 USP8 CACNA1G MAPK8 DAGLA | 8.79e-04 | 858 | 115 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1B RELN EPHA6 GRIA1 GRIA2 GRIA3 GRIA4 SPG11 GRM5 USP8 CACNA1G MAPK8 DAGLA | 8.98e-04 | 860 | 115 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | leading edge membrane | 1.09e-03 | 210 | 115 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.14e-03 | 212 | 115 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | presynapse | CACNA1B SCN11A STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D ZDHHC17 SLC22A1 RIMS1 RIMS2 DNM2 | 1.18e-03 | 886 | 115 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | perikaryon | 1.48e-03 | 223 | 115 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1B SCN11A RELN GRIA1 GRIA2 GRIA3 GRIA4 HMCN2 CACNA1G MAPK8 MAPK9 MAPK10 | 2.17e-03 | 835 | 115 | 12 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.49e-03 | 49 | 115 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 2.61e-03 | 14 | 115 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.65e-03 | 431 | 115 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 3.21e-03 | 110 | 115 | 4 | GO:0120111 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 3.25e-03 | 350 | 115 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | dendrite membrane | 3.64e-03 | 56 | 115 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.64e-03 | 56 | 115 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.87e-03 | 17 | 115 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 4.33e-03 | 18 | 115 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 4.33e-03 | 18 | 115 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | cell cortex | 4.47e-03 | 371 | 115 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | lysosome | SLC37A3 LARS1 SPG11 ARL8A CHIT1 USP6 ARSD ARL8B SCARB1 USP4 FUCA2 | 5.11e-03 | 811 | 115 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | SLC37A3 LARS1 SPG11 ARL8A CHIT1 USP6 ARSD ARL8B SCARB1 USP4 FUCA2 | 5.11e-03 | 811 | 115 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | cell body | CACNA1B SCN11A RELN GRIA1 GRIA2 GRIA3 GRIA4 HMCN2 CACNA1G MAPK8 MAPK9 MAPK10 | 5.12e-03 | 929 | 115 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MRC1 STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 ARL8A ZDHHC17 LRIG3 USP8 ARL8B SCARB1 PKD2 DAGLA DNM2 | 5.34e-03 | 1307 | 115 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MRC1 STXBP5 GRIA1 GRIA2 GRIA3 GRIA4 ARL8A ZDHHC17 LRIG3 USP8 ARL8B SCARB1 PKD2 DAGLA DNM2 | 6.05e-03 | 1325 | 115 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 7.04e-03 | 23 | 115 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | midbody | 7.71e-03 | 222 | 115 | 5 | GO:0030496 | |
| GeneOntologyCellularComponent | lamellipodium | 8.91e-03 | 230 | 115 | 5 | GO:0030027 | |
| MousePheno | abnormal single cell response | 3.60e-06 | 35 | 95 | 5 | MP:0003463 | |
| MousePheno | abnormal excitatory postsynaptic potential | 5.85e-06 | 102 | 95 | 7 | MP:0002912 | |
| MousePheno | abnormal synaptic transmission | CACNA1B SCN11A RELN TRIB2 DHX58 TOX STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 ZDHHC17 GRM5 ARL8B DHFR2 CACNA1G MAPK9 DAGLA KCNT1 | 2.70e-05 | 1070 | 95 | 20 | MP:0003635 |
| MousePheno | abnormal CNS synaptic transmission | CACNA1B SCN11A RELN TRIB2 DHX58 TOX STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 ZDHHC17 GRM5 ARL8B DHFR2 MAPK9 DAGLA KCNT1 | 2.90e-05 | 985 | 95 | 19 | MP:0002206 |
| MousePheno | abnormal synaptic physiology | CACNA1B SCN11A RELN TRIB2 DHX58 TOX STXBP5 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 ZDHHC17 GRM5 ARL8B DHFR2 CACNA1G MAPK9 DAGLA KCNT1 | 2.93e-05 | 1076 | 95 | 20 | MP:0021009 |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 4.17e-05 | 29 | 95 | 4 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 4.17e-05 | 29 | 95 | 4 | MP:0002887 | |
| MousePheno | abnormal gait | CACNA1B RELN STXBP5 HMBS GRIA1 SPG11 NEB CMAS STK3 ATP5MG LRIG3 CACNA1G DNM2 | 4.81e-05 | 520 | 95 | 13 | MP:0001406 |
| MousePheno | abnormal channel response | 7.04e-05 | 33 | 95 | 4 | MP:0003484 | |
| MousePheno | abnormal nervous system electrophysiology | CACNA1B SCN11A TRPC4 GRIA2 GRIA4 GRM5 CACNA1G DAGLA KCNT1 DNM2 | 7.82e-05 | 329 | 95 | 10 | MP:0002272 |
| MousePheno | impaired ability to fire action potentials | 8.28e-05 | 13 | 95 | 3 | MP:0002578 | |
| MousePheno | abnormal skin morphology | NUGGC SCN11A FRAS1 RELN FN1 EPHA6 ERN1 PPM1D APBB2 CDK11A ZMIZ1 NEK9 PHKA1 LRIG3 XIRP2 DHFR2 CACNA1G MAPK8 MAPK9 ALG6 WDR49 TRIB1 ACOXL | 8.51e-05 | 1455 | 95 | 23 | MP:0002060 |
| MousePheno | abnormal locomotor coordination | CACNA1B RELN STXBP5 HMBS GRIA1 SPG11 ZDHHC17 NEB CMAS STK3 ATP5MG LRIG3 CYCS CACNA1G DNM2 | 1.06e-04 | 726 | 95 | 15 | MP:0003312 |
| MousePheno | abnormal long-term potentiation | 1.28e-04 | 221 | 95 | 8 | MP:0002207 | |
| MousePheno | decreased alcohol consumption | 1.60e-04 | 16 | 95 | 3 | MP:0003546 | |
| MousePheno | decreased fluid intake | 1.67e-04 | 41 | 95 | 4 | MP:0011942 | |
| MousePheno | abnormal nociception after inflammation | 2.21e-04 | 44 | 95 | 4 | MP:0002736 | |
| MousePheno | abnormal touch/ nociception | CACNA1B SCN11A GRIA1 GRIA2 GRIA3 GRIA4 GRM5 FGF11 TRIB1 KCNT1 | 2.33e-04 | 376 | 95 | 10 | MP:0001968 |
| Domain | Kinase-like_dom | TRIB2 EPHA6 ERN1 CDK11A ALPK1 NEK9 PRKD3 STK3 NEK2 BTK MACF1 MAPK8 MAPK9 MAPK10 STK24 TRIB1 DNM2 | 3.59e-08 | 542 | 115 | 17 | IPR011009 |
| Domain | Lig_chan-Glu_bd | 6.52e-08 | 18 | 115 | 5 | PF10613 | |
| Domain | Glu/Gly-bd | 6.52e-08 | 18 | 115 | 5 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.52e-08 | 18 | 115 | 5 | SM00918 | |
| Domain | Iontro_rcpt | 6.52e-08 | 18 | 115 | 5 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.52e-08 | 18 | 115 | 5 | IPR001508 | |
| Domain | Lig_chan | 6.52e-08 | 18 | 115 | 5 | PF00060 | |
| Domain | PBPe | 6.52e-08 | 18 | 115 | 5 | SM00079 | |
| Domain | ANF_lig-bd_rcpt | 9.51e-08 | 37 | 115 | 6 | IPR001828 | |
| Domain | ANF_receptor | 9.51e-08 | 37 | 115 | 6 | PF01094 | |
| Domain | Peripla_BP_I | 1.32e-07 | 39 | 115 | 6 | IPR028082 | |
| Domain | Prot_kinase_dom | TRIB2 EPHA6 ERN1 CDK11A NEK9 PRKD3 STK3 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 1.88e-06 | 489 | 115 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TRIB2 EPHA6 ERN1 CDK11A NEK9 PRKD3 STK3 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 2.06e-06 | 493 | 115 | 14 | PS50011 |
| Domain | MAPK_JNK | 2.25e-06 | 5 | 115 | 3 | IPR008351 | |
| Domain | Pkinase | TRIB2 ERN1 CDK11A NEK9 PRKD3 STK3 NEK2 MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 4.08e-06 | 381 | 115 | 12 | PF00069 |
| Domain | S_TKc | ERN1 CDK11A NEK9 PRKD3 STK3 NEK2 MAPK8 MAPK9 MAPK10 STK24 TRIB1 | 1.36e-05 | 359 | 115 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ATP | EPHA6 ERN1 CDK11A NEK9 PRKD3 STK3 NEK2 BTK MAPK8 MAPK9 MAPK10 STK24 | 2.63e-05 | 459 | 115 | 12 | PS00107 |
| Domain | MAGEA3/MAGEA6 | 3.76e-05 | 2 | 115 | 2 | IPR030097 | |
| Domain | MAPK | 4.80e-05 | 12 | 115 | 3 | PS01351 | |
| Domain | MAP_kinase_CS | 4.80e-05 | 12 | 115 | 3 | IPR003527 | |
| Domain | Ser/Thr_kinase_AS | 7.23e-05 | 357 | 115 | 10 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 8.11e-05 | 362 | 115 | 10 | PS00108 | |
| Domain | Tribbles/Ser_Thr_kinase_40 | 2.24e-04 | 4 | 115 | 2 | IPR024104 | |
| Domain | MAGE_N | 2.40e-04 | 20 | 115 | 3 | SM01392 | |
| Domain | MAGE_N | 3.22e-04 | 22 | 115 | 3 | PF12440 | |
| Domain | MAGE_N | 3.22e-04 | 22 | 115 | 3 | IPR021072 | |
| Domain | Channel_four-helix_dom | 4.19e-04 | 57 | 115 | 4 | IPR027359 | |
| Domain | - | 4.19e-04 | 57 | 115 | 4 | 1.20.120.350 | |
| Domain | MAGE | 1.18e-03 | 34 | 115 | 3 | SM01373 | |
| Domain | MAGE | 1.40e-03 | 36 | 115 | 3 | PS50838 | |
| Domain | MHD_dom | 1.40e-03 | 36 | 115 | 3 | IPR002190 | |
| Domain | MAGE | 1.40e-03 | 36 | 115 | 3 | PF01454 | |
| Domain | VDCCAlpha1 | 1.64e-03 | 10 | 115 | 2 | IPR002077 | |
| Domain | FYVE_2 | 1.99e-03 | 11 | 115 | 2 | PF02318 | |
| Domain | RABBD | 2.38e-03 | 12 | 115 | 2 | PS50916 | |
| Domain | Rab_BD | 2.38e-03 | 12 | 115 | 2 | IPR010911 | |
| Domain | 6-hairpin_glycosidase-like | 2.80e-03 | 13 | 115 | 2 | IPR008928 | |
| Domain | - | 2.80e-03 | 13 | 115 | 2 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 3.26e-03 | 14 | 115 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.26e-03 | 14 | 115 | 2 | PS51092 | |
| Domain | FN2_1 | 3.26e-03 | 14 | 115 | 2 | PS00023 | |
| Domain | fn2 | 3.26e-03 | 14 | 115 | 2 | PF00040 | |
| Domain | FN2 | 3.26e-03 | 14 | 115 | 2 | SM00059 | |
| Domain | Dynamin_GTPase | 3.74e-03 | 15 | 115 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 3.74e-03 | 15 | 115 | 2 | IPR022812 | |
| Domain | Dynamin_N | 3.74e-03 | 15 | 115 | 2 | PF00350 | |
| Domain | Ion_trans_dom | 5.41e-03 | 114 | 115 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.41e-03 | 114 | 115 | 4 | PF00520 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY | 5.12e-08 | 7 | 89 | 4 | M47697 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 7.19e-08 | 18 | 89 | 5 | M48098 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.68e-07 | 21 | 89 | 5 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.17e-07 | 22 | 89 | 5 | MM15104 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY | 2.41e-06 | 5 | 89 | 3 | M47570 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY | 2.41e-06 | 5 | 89 | 3 | M49021 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY | 2.41e-06 | 5 | 89 | 3 | M49005 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.50e-06 | 35 | 89 | 5 | MM15109 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.55e-06 | 16 | 89 | 4 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 3.32e-06 | 17 | 89 | 4 | M5488 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 4.80e-06 | 6 | 89 | 3 | M47680 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY | 4.80e-06 | 6 | 89 | 3 | M47698 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY | 4.80e-06 | 6 | 89 | 3 | M47712 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 5.61e-06 | 41 | 89 | 5 | M39655 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.66e-06 | 20 | 89 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 8.18e-06 | 21 | 89 | 4 | M27736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY | 8.36e-06 | 7 | 89 | 3 | M47711 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 9.95e-06 | 22 | 89 | 4 | M39795 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.11e-05 | 47 | 89 | 5 | M19708 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY | 1.33e-05 | 8 | 89 | 3 | M47814 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 2.71e-05 | 28 | 89 | 4 | M39572 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.83e-05 | 10 | 89 | 3 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.83e-05 | 10 | 89 | 3 | M13962 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.87e-05 | 140 | 89 | 7 | M42572 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.12e-05 | 29 | 89 | 4 | MM15028 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 3.12e-05 | 29 | 89 | 4 | M39676 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.10e-05 | 31 | 89 | 4 | M7223 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 5.14e-05 | 12 | 89 | 3 | M47929 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.51e-05 | 211 | 89 | 8 | MM14502 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 6.36e-05 | 67 | 89 | 5 | MM15327 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 6.65e-05 | 13 | 89 | 3 | M47594 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 8.36e-05 | 37 | 89 | 4 | MM14899 | |
| Pathway | PID_FAS_PATHWAY | 9.30e-05 | 38 | 89 | 4 | M94 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.05e-04 | 119 | 89 | 6 | MM14901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M47569 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.66e-04 | 44 | 89 | 4 | M175 | |
| Pathway | KEGG_N_GLYCAN_BIOSYNTHESIS | 1.98e-04 | 46 | 89 | 4 | M11079 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.15e-04 | 47 | 89 | 4 | M39829 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY | 2.19e-04 | 19 | 89 | 3 | M47471 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.20e-04 | 87 | 89 | 5 | M27617 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS | 2.57e-04 | 20 | 89 | 3 | M27274 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP | 2.57e-04 | 20 | 89 | 3 | M47928 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.60e-04 | 335 | 89 | 9 | MM14503 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 2.96e-04 | 144 | 89 | 6 | M39691 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.02e-04 | 270 | 89 | 8 | M15514 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.16e-04 | 94 | 89 | 5 | M2843 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 3.43e-04 | 53 | 89 | 4 | M3812 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 3.43e-04 | 22 | 89 | 3 | M859 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.93e-04 | 23 | 89 | 3 | M47666 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 3.93e-04 | 23 | 89 | 3 | MM15134 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 3.93e-04 | 23 | 89 | 3 | M27949 | |
| Pathway | WP_NGLYCAN_BIOSYNTHESIS | 4.54e-04 | 57 | 89 | 4 | M48051 | |
| Pathway | WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS | 5.06e-04 | 25 | 89 | 3 | M39813 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 5.53e-04 | 60 | 89 | 4 | M39583 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 5.69e-04 | 26 | 89 | 3 | M47565 | |
| Pathway | KEGG_COLORECTAL_CANCER | 6.26e-04 | 62 | 89 | 4 | M14631 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 7.11e-04 | 28 | 89 | 3 | MM15132 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 7.16e-04 | 170 | 89 | 6 | M7494 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 7.89e-04 | 29 | 89 | 3 | M47466 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE | 7.97e-04 | 115 | 89 | 5 | M27013 | |
| Pathway | PID_P75_NTR_PATHWAY | 8.88e-04 | 68 | 89 | 4 | M153 | |
| Pathway | WP_MAPK_SIGNALING | 9.24e-04 | 246 | 89 | 7 | M39597 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 9.39e-04 | 69 | 89 | 4 | M48052 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 9.62e-04 | 31 | 89 | 3 | M15195 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 9.62e-04 | 31 | 89 | 3 | M193 | |
| Pathway | PID_CD40_PATHWAY | 9.62e-04 | 31 | 89 | 3 | M45 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 9.91e-04 | 70 | 89 | 4 | M8232 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.91e-04 | 70 | 89 | 4 | M3115 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 1.04e-03 | 122 | 89 | 5 | MM14640 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.04e-03 | 71 | 89 | 4 | M15913 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.06e-03 | 32 | 89 | 3 | M23 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.13e-03 | 411 | 89 | 9 | M735 | |
| Pathway | PID_NCADHERIN_PATHWAY | 1.16e-03 | 33 | 89 | 3 | M266 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 1.16e-03 | 73 | 89 | 4 | M39758 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.16e-03 | 73 | 89 | 4 | MM16641 | |
| Pathway | SIG_CD40PATHWAYMAP | 1.26e-03 | 34 | 89 | 3 | M12705 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 1.41e-03 | 77 | 89 | 4 | MM15118 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 1.48e-03 | 78 | 89 | 4 | M39824 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.48e-03 | 267 | 89 | 7 | M10792 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.49e-03 | 36 | 89 | 3 | M39699 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.49e-03 | 36 | 89 | 3 | M39908 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.53e-03 | 197 | 89 | 6 | M27188 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 1.55e-03 | 79 | 89 | 4 | M897 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 1.55e-03 | 79 | 89 | 4 | M11816 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 1.66e-03 | 200 | 89 | 6 | M48048 | |
| Pathway | REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE | 2.04e-03 | 85 | 89 | 4 | MM14645 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.04e-03 | 85 | 89 | 4 | M3578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 2.09e-03 | 11 | 89 | 2 | M47614 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.16e-03 | 144 | 89 | 5 | MM14501 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.20e-03 | 367 | 89 | 8 | M48346 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.67e-03 | 44 | 89 | 3 | MM15878 | |
| Pathway | REACTOME_HEME_BIOSYNTHESIS | 2.94e-03 | 13 | 89 | 2 | MM14720 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 2.98e-03 | 155 | 89 | 5 | MM14665 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 3.04e-03 | 46 | 89 | 3 | M39805 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 3.23e-03 | 47 | 89 | 3 | M39380 | |
| Pathway | REACTOME_HEME_BIOSYNTHESIS | 3.41e-03 | 14 | 89 | 2 | M27059 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 3.54e-03 | 99 | 89 | 4 | MM14660 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 3.63e-03 | 49 | 89 | 3 | M39543 | |
| Pathway | PID_FOXO_PATHWAY | 3.63e-03 | 49 | 89 | 3 | M136 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 3.92e-03 | 15 | 89 | 2 | M47691 | |
| Pubmed | 8.26e-12 | 7 | 117 | 5 | 21368048 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 1.22e-10 | 4 | 117 | 4 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 1.22e-10 | 4 | 117 | 4 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 1.22e-10 | 4 | 117 | 4 | 17828255 | |
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 24652293 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 1.22e-10 | 4 | 117 | 4 | 12692557 | |
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 12125045 | ||
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 10688364 | ||
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 17409242 | ||
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 14561864 | ||
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 1319477 | ||
| Pubmed | 1.22e-10 | 4 | 117 | 4 | 9648857 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.63e-10 | 24 | 117 | 6 | 35746896 | |
| Pubmed | 1.66e-10 | 45 | 117 | 7 | 25979088 | ||
| Pubmed | 6.07e-10 | 5 | 117 | 4 | 16129400 | ||
| Pubmed | 6.07e-10 | 5 | 117 | 4 | 9482932 | ||
| Pubmed | 1.16e-09 | 15 | 117 | 5 | 9481670 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 4.22e-09 | 7 | 117 | 4 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 4.22e-09 | 7 | 117 | 4 | 9016303 | |
| Pubmed | 4.22e-09 | 7 | 117 | 4 | 27076426 | ||
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 4.22e-09 | 7 | 117 | 4 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 4.22e-09 | 7 | 117 | 4 | 9651535 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 6.92e-09 | 118 | 117 | 8 | 19156168 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 8.43e-09 | 8 | 117 | 4 | 23217150 | |
| Pubmed | 1.51e-08 | 9 | 117 | 4 | 24292102 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.51e-08 | 9 | 117 | 4 | 9051806 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 30685843 | ||
| Pubmed | JNK1 is required to preserve cardiac function in the early response to pressure overload. | 3.71e-08 | 3 | 117 | 3 | 16579967 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 34426577 | ||
| Pubmed | Specific pathophysiological functions of JNK isoforms in the brain. | 3.71e-08 | 3 | 117 | 3 | 15673436 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15144856 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 23485395 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 18163426 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 12700243 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 12172541 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 17056565 | ||
| Pubmed | The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases. | 3.71e-08 | 3 | 117 | 3 | 34502556 | |
| Pubmed | Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | 3.71e-08 | 3 | 117 | 3 | 22122651 | |
| Pubmed | Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning. | 3.71e-08 | 3 | 117 | 3 | 20926661 | |
| Pubmed | Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting. | 3.71e-08 | 3 | 117 | 3 | 28630296 | |
| Pubmed | JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis. | 3.71e-08 | 3 | 117 | 3 | 19609503 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 36070750 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 22094384 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 32569783 | ||
| Pubmed | Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex. | 3.71e-08 | 3 | 117 | 3 | 36223737 | |
| Pubmed | Persistent synaptic scaling independent of AMPA receptor subunit composition. | 3.71e-08 | 3 | 117 | 3 | 23864664 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 22057216 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15246824 | ||
| Pubmed | A critical role of neural-specific JNK3 for ischemic apoptosis. | 3.71e-08 | 3 | 117 | 3 | 14657393 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15474087 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15145077 | ||
| Pubmed | Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. | 3.71e-08 | 3 | 117 | 3 | 28290985 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 14517246 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 26585043 | ||
| Pubmed | Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. | 3.71e-08 | 3 | 117 | 3 | 14687553 | |
| Pubmed | Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2. | 3.71e-08 | 3 | 117 | 3 | 29180434 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 19217372 | ||
| Pubmed | Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes. | 3.71e-08 | 3 | 117 | 3 | 23428746 | |
| Pubmed | Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. | 3.71e-08 | 3 | 117 | 3 | 19409270 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 21135237 | ||
| Pubmed | LTP requires a reserve pool of glutamate receptors independent of subunit type. | 3.71e-08 | 3 | 117 | 3 | 23235828 | |
| Pubmed | 3.94e-08 | 11 | 117 | 4 | 15123655 | ||
| Pubmed | Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. | 3.94e-08 | 11 | 117 | 4 | 16481105 | |
| Pubmed | 5.90e-08 | 12 | 117 | 4 | 11891216 | ||
| Pubmed | 8.50e-08 | 13 | 117 | 4 | 25218043 | ||
| Pubmed | 1.19e-07 | 14 | 117 | 4 | 19805353 | ||
| Pubmed | From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. | 1.19e-07 | 14 | 117 | 4 | 16880397 | |
| Pubmed | Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). | 1.48e-07 | 4 | 117 | 3 | 15228592 | |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 28608780 | ||
| Pubmed | JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. | 1.48e-07 | 4 | 117 | 3 | 12818176 | |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 20525557 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 9393873 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 15528206 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 9619499 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 1.48e-07 | 4 | 117 | 3 | 10027300 | |
| Pubmed | A selective small-molecule inhibitor of c-Jun N-terminal kinase 1. | 1.48e-07 | 4 | 117 | 3 | 19527717 | |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 23664612 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 30931998 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 29581259 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 12414093 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 11466342 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 26932439 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 16824735 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 31231192 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 22372722 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 31992779 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 15693750 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 10471813 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 29915039 | ||
| Pubmed | Long-term potentiation is independent of the C-tail of the GluA1 AMPA receptor subunit. | 1.48e-07 | 4 | 117 | 3 | 32831170 | |
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 1.48e-07 | 4 | 117 | 3 | 29515177 | |
| Pubmed | APP upregulation contributes to retinal ganglion cell degeneration via JNK3. | 1.48e-07 | 4 | 117 | 3 | 29238071 | |
| Pubmed | Cortical interneurons require Jnk1 to enter and navigate the developing cerebral cortex. | 1.48e-07 | 4 | 117 | 3 | 24899703 | |
| Pubmed | AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. | 1.48e-07 | 4 | 117 | 3 | 19004011 | |
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 2.15e-07 | 16 | 117 | 4 | 16055064 | |
| Pubmed | 3.36e-07 | 81 | 117 | 6 | 22723691 | ||
| Pubmed | 3.59e-07 | 18 | 117 | 4 | 12588844 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 3.59e-07 | 18 | 117 | 4 | 18311135 | |
| Pubmed | 3.59e-07 | 18 | 117 | 4 | 14730302 | ||
| Pubmed | Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission. | 3.69e-07 | 5 | 117 | 3 | 31492534 | |
| Interaction | GRIA3 interactions | 4.68e-06 | 43 | 116 | 5 | int:GRIA3 | |
| Cytoband | 11q23.3 | 4.94e-05 | 78 | 117 | 4 | 11q23.3 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 3.93e-10 | 4 | 82 | 4 | 1200 | |
| GeneFamily | Mitogen-activated protein kinases | 2.49e-05 | 13 | 82 | 3 | 651 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 1.21e-04 | 4 | 82 | 2 | 833 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 7.17e-04 | 9 | 82 | 2 | 430 | |
| GeneFamily | MAGE family | 7.87e-04 | 40 | 82 | 3 | 1136 | |
| GeneFamily | Ubiquitin specific peptidases | 2.10e-03 | 56 | 82 | 3 | 366 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.45e-03 | 206 | 82 | 5 | 682 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.15e-03 | 26 | 82 | 2 | 253 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.63e-03 | 27 | 82 | 2 | 1253 | |
| GeneFamily | Transient receptor potential cation channels | 7.12e-03 | 28 | 82 | 2 | 249 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 8.68e-03 | 31 | 82 | 2 | 357 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 3.24e-06 | 140 | 117 | 7 | M617 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 4.28e-06 | 146 | 117 | 7 | MM964 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 9.95e-06 | 166 | 117 | 7 | M5354 | |
| Coexpression | DCA_UP.V1_UP | 2.08e-05 | 186 | 117 | 7 | M2762 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 1.56e-05 | 206 | 114 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | RELN ADAMTSL1 TRIB2 SLC37A3 GRIA1 COX15 GRIA4 CNTLN FAP DCUN1D1 ANAPC1 | 1.69e-05 | 421 | 114 | 11 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 1.76e-05 | 60 | 114 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 3.85e-05 | 116 | 114 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | ADAMTSL1 TRIB2 FN1 TOX SWAP70 GRIA3 ALPK1 CNTLN GBA2 PTGFRN LRIG3 FAP PHLDB1 SCARB1 JOSD1 CACNA1G RIMS1 DAGLA | 9.36e-05 | 1228 | 114 | 18 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_100 | 1.06e-04 | 87 | 114 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | ADAMTSL1 TRIB2 FN1 TOX GRIA3 GRIA4 ALPK1 CNTLN PTGFRN NEK9 LRIG3 FAP PKD2 FGF11 CACNA1G RIMS1 MAPK9 | 1.32e-04 | 1148 | 114 | 17 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.32e-07 | 148 | 117 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.16e-07 | 159 | 117 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.69e-07 | 188 | 117 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.94e-07 | 189 | 117 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 192 | 117 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.85e-07 | 196 | 117 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-07 | 198 | 117 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-07 | 198 | 117 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.01e-06 | 200 | 117 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 162 | 117 | 6 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.84e-06 | 186 | 117 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 196 | 117 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 196 | 117 | 6 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.40e-05 | 198 | 117 | 6 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 117 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 117 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 117 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 117 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 150 | 117 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-05 | 162 | 117 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-05 | 165 | 117 | 5 | 0ae39c9a6d1265d65dc0660924612cfe11e489ec | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-05 | 165 | 117 | 5 | 686cf89077cc7b744a6127de2b34d8c27da8b6c4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-05 | 165 | 117 | 5 | a5ed8c331d5551cd8bce50bdc31cb893218317cd | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-05 | 169 | 117 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.13e-05 | 172 | 117 | 5 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.64e-05 | 174 | 117 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.91e-05 | 175 | 117 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.91e-05 | 175 | 117 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 176 | 117 | 5 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 176 | 117 | 5 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 176 | 117 | 5 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-04 | 177 | 117 | 5 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-04 | 177 | 117 | 5 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.13e-04 | 180 | 117 | 5 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-04 | 180 | 117 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 180 | 117 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 180 | 117 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.19e-04 | 182 | 117 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 182 | 117 | 5 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 182 | 117 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 182 | 117 | 5 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.22e-04 | 183 | 117 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 183 | 117 | 5 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 183 | 117 | 5 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 184 | 117 | 5 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 117 | 5 | 2c8e9ddce3e60302965dcf9dee77c4fe33e4071d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 185 | 117 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 185 | 117 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 117 | 5 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 187 | 117 | 5 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.35e-04 | 187 | 117 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-04 | 188 | 117 | 5 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 188 | 117 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-04 | 188 | 117 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 189 | 117 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 189 | 117 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 189 | 117 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-04 | 190 | 117 | 5 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.46e-04 | 190 | 117 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.46e-04 | 190 | 117 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-04 | 191 | 117 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.49e-04 | 191 | 117 | 5 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-04 | 191 | 117 | 5 | 7b4b5d90d1023d03239ed986f273afa734d3124d | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.49e-04 | 191 | 117 | 5 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.49e-04 | 191 | 117 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 192 | 117 | 5 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.53e-04 | 192 | 117 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 192 | 117 | 5 | 6417468829517a0f6e04e7e44eec1622001d4c5c | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 192 | 117 | 5 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.53e-04 | 192 | 117 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 193 | 117 | 5 | 1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 193 | 117 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 193 | 117 | 5 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.57e-04 | 193 | 117 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 193 | 117 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 193 | 117 | 5 | b9c00df1b216eaa4283315713f1c9ef552d3d435 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 194 | 117 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 194 | 117 | 5 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 194 | 117 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 195 | 117 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 195 | 117 | 5 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.64e-04 | 195 | 117 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 195 | 117 | 5 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 196 | 117 | 5 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 196 | 117 | 5 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-04 | 196 | 117 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-04 | 196 | 117 | 5 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-04 | 196 | 117 | 5 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-04 | 197 | 117 | 5 | d8f99a9f2367c8bc9308b0c64d0226875262927a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-04 | 197 | 117 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 1.72e-04 | 197 | 117 | 5 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.72e-04 | 197 | 117 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-04 | 197 | 117 | 5 | 1bf69db7e830315c8fa85e6e85b0cb94014e9169 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.72e-04 | 197 | 117 | 5 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 198 | 117 | 5 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| Drug | Ns102 | 3.48e-15 | 25 | 117 | 9 | CID005311098 | |
| Drug | BAPTA | CACNA1B FN1 TRPC4 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 PRKD3 FAP CYCS MAPK8 MAPK9 MAPK10 CABIN1 | 1.08e-11 | 324 | 117 | 16 | CID000104751 |
| Drug | 6,7-dinitroquinoxaline | 3.02e-10 | 33 | 117 | 7 | CID002724608 | |
| Drug | GYKI 52466 | 5.90e-10 | 58 | 117 | 8 | CID000003538 | |
| Drug | 3-pyridazinol 1-oxide | 6.62e-10 | 4 | 117 | 4 | CID000574311 | |
| Drug | YM90K | 1.52e-09 | 23 | 117 | 6 | CID005486547 | |
| Drug | CGP 39653 | 2.02e-09 | 24 | 117 | 6 | CID006437837 | |
| Drug | 1NaPP1 | 2.53e-09 | 12 | 117 | 5 | CID000004877 | |
| Drug | AC1L1YEG | 3.30e-09 | 5 | 117 | 4 | CID000063114 | |
| Drug | Chicago acid | 3.30e-09 | 5 | 117 | 4 | CID000065740 | |
| Drug | CHEBI:570577 | 3.30e-09 | 5 | 117 | 4 | CID011334126 | |
| Drug | 1-BCP | 3.30e-09 | 5 | 117 | 4 | CID000001370 | |
| Drug | irampanel | 3.30e-09 | 5 | 117 | 4 | CID003038472 | |
| Drug | LY395153 | 3.30e-09 | 5 | 117 | 4 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 3.30e-09 | 5 | 117 | 4 | CID000107978 | |
| Drug | 5-h PCA | 3.30e-09 | 5 | 117 | 4 | CID000129091 | |
| Drug | AC1NUW3V | 6.98e-09 | 29 | 117 | 6 | CID005462126 | |
| Drug | LY293558 | 8.69e-09 | 30 | 117 | 6 | CID000127894 | |
| Drug | AC1L32TU | 8.69e-09 | 30 | 117 | 6 | CID000107831 | |
| Drug | thiokynurenic acid | 9.48e-09 | 15 | 117 | 5 | CID003035667 | |
| Drug | YM928 | 9.86e-09 | 6 | 117 | 4 | CID006918393 | |
| Drug | 2cmo | 9.86e-09 | 6 | 117 | 4 | CID006914597 | |
| Drug | 4-methylglutamic acid | 1.07e-08 | 31 | 117 | 6 | CID000005365 | |
| Drug | eliprodil | 1.07e-08 | 31 | 117 | 6 | CID000060703 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 1.31e-08 | 32 | 117 | 6 | CID000001222 | |
| Drug | LY233536 | 1.37e-08 | 16 | 117 | 5 | CID000126239 | |
| Drug | D-CPPene | 1.93e-08 | 34 | 117 | 6 | CID006435801 | |
| Drug | 7-Cl-Thio-Kyna | 1.94e-08 | 17 | 117 | 5 | CID003035668 | |
| Drug | hexachlorophene | 2.08e-08 | 90 | 117 | 8 | CID000003598 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 2.29e-08 | 7 | 117 | 4 | CID000127988 | |
| Drug | thio-ATPA | 2.29e-08 | 7 | 117 | 4 | CID005289517 | |
| Drug | fludelone | 2.29e-08 | 7 | 117 | 4 | CID006918712 | |
| Drug | kainite | 2.33e-08 | 35 | 117 | 6 | CID000164810 | |
| Drug | MNQX | 2.67e-08 | 18 | 117 | 5 | CID000130818 | |
| Drug | R,S)-AMPA | 2.78e-08 | 36 | 117 | 6 | CID000001221 | |
| Drug | C6H12NO5P | 2.78e-08 | 36 | 117 | 6 | CID000104962 | |
| Drug | LY382884 | 3.61e-08 | 19 | 117 | 5 | CID000656723 | |
| Drug | L-BMAA | 3.91e-08 | 38 | 117 | 6 | CID000028558 | |
| Drug | CGS 19755 | 3.91e-08 | 38 | 117 | 6 | CID000068736 | |
| Drug | homoibotenic acid | 4.56e-08 | 8 | 117 | 4 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 4.56e-08 | 8 | 117 | 4 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 4.56e-08 | 8 | 117 | 4 | CID003614351 | |
| Drug | 2,3-PDCA | 4.56e-08 | 8 | 117 | 4 | CID000127037 | |
| Drug | HA-966 | 4.60e-08 | 39 | 117 | 6 | CID000001232 | |
| Drug | DETC-MeSO | 4.60e-08 | 39 | 117 | 6 | CID003035711 | |
| Drug | IDRA 21 | 4.79e-08 | 20 | 117 | 5 | CID000003688 | |
| Drug | L000369 | 6.28e-08 | 41 | 117 | 6 | CID003931705 | |
| Drug | AC1NNRU4 | 6.28e-08 | 41 | 117 | 6 | CID005126051 | |
| Drug | NS 102 | 8.07e-08 | 22 | 117 | 5 | CID005282252 | |
| Drug | CX516 | 8.07e-08 | 22 | 117 | 5 | CID000148184 | |
| Drug | 1m5b | 8.18e-08 | 9 | 117 | 4 | CID000447081 | |
| Drug | Ly294486 | 8.18e-08 | 9 | 117 | 4 | CID005311255 | |
| Drug | isothiazol-3-one | 8.18e-08 | 9 | 117 | 4 | CID000096917 | |
| Drug | LY341495 | 8.45e-08 | 43 | 117 | 6 | CID006324636 | |
| Drug | Joro spider toxin | 8.45e-08 | 43 | 117 | 6 | CID000119582 | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A | GRIA3 PTPN22 ALPK1 ANGPTL2 CACNA1G RIMS1 MAPK10 DAGLA STK24 DNASE1L2 | 8.62e-08 | 200 | 117 | 10 | 3773_UP |
| Drug | glutamate | CACNA1B PSAT1 RELN TRPC4 LARS1 HMBS GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 PRKD3 DHFR2 CYCS PKD2 CACNA1G RIMS1 MAPK10 CABIN1 | 9.42e-08 | 962 | 117 | 20 | CID000000611 |
| Drug | AC1L9FMM | 9.72e-08 | 73 | 117 | 7 | CID000444055 | |
| Drug | 7-chlorokynurenic acid | 1.12e-07 | 45 | 117 | 6 | CID000001884 | |
| Drug | 2-amino-3-phosphonopropionic acid | 1.29e-07 | 76 | 117 | 7 | CID000003857 | |
| Drug | benzothiazol-2-ylacetonitrile | 1.32e-07 | 3 | 117 | 3 | CID000342465 | |
| Drug | Benzoates | 1.36e-07 | 10 | 117 | 4 | ctd:D001565 | |
| Drug | gavestinel | 1.61e-07 | 25 | 117 | 5 | CID006450546 | |
| Drug | methylenecyclopropylglycine | 1.89e-07 | 49 | 117 | 6 | CID000441452 | |
| Drug | J-ST | 2.13e-07 | 11 | 117 | 4 | CID005288655 | |
| Drug | YM872 | 2.13e-07 | 11 | 117 | 4 | CID000148200 | |
| Drug | 0-ol | 2.13e-07 | 11 | 117 | 4 | CID000069892 | |
| Drug | sym 2206 | 2.13e-07 | 11 | 117 | 4 | CID005039877 | |
| Drug | gabapentin | 2.30e-07 | 169 | 117 | 9 | CID000003446 | |
| Drug | DNQX | 2.37e-07 | 83 | 117 | 7 | CID003899541 | |
| Drug | AC1L63MU | GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 PTGFRN PRKD3 FAP MAPK8 MAPK9 MAPK10 | 2.38e-07 | 347 | 117 | 12 | CID000285703 |
| Drug | LY354740 | 2.41e-07 | 51 | 117 | 6 | CID000114827 | |
| Drug | L-689,560 | 2.42e-07 | 27 | 117 | 5 | CID000121918 | |
| Drug | D-N-Q | 2.58e-07 | 84 | 117 | 7 | CID000003140 | |
| Drug | AC1L1EKQ | 2.72e-07 | 52 | 117 | 6 | CID000002834 | |
| Drug | NSC618487 | FN1 EPHA6 ERN1 APBB2 GRIN2D GRM5 NEK9 STT3A PRKD3 NEK2 SCARB1 BTK CYCS MAPK8 MAPK9 MAPK10 CABIN1 DAGLA STK24 | 2.82e-07 | 933 | 117 | 19 | CID000005279 |
| Drug | C-PP | 2.94e-07 | 28 | 117 | 5 | CID000001228 | |
| Drug | aptiganel | 2.94e-07 | 28 | 117 | 5 | CID000060839 | |
| Drug | riluzole | 2.94e-07 | 174 | 117 | 9 | CID000005070 | |
| Drug | memantine | 3.03e-07 | 86 | 117 | 7 | CID000004054 | |
| Drug | KN-62 | CACNA1B FN1 GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D PRKD3 MAPK8 CABIN1 | 3.16e-07 | 230 | 117 | 10 | CID000003838 |
| Drug | Atpa | 3.18e-07 | 12 | 117 | 4 | CID000002252 | |
| Drug | C-X6 | 3.18e-07 | 12 | 117 | 4 | CID005288002 | |
| Drug | rufinamide | 3.54e-07 | 29 | 117 | 5 | CID000129228 | |
| Drug | ketobemidone | 3.54e-07 | 29 | 117 | 5 | CID000010101 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | AKAP6 CACNA1B GRIA1 GRIA2 GRIA3 GRIA4 GRM5 PRKD3 PKD2 CABIN1 | 3.56e-07 | 233 | 117 | 10 | CID000005114 |
| Drug | cis-2,3-piperidine dicarboxylic acid | 4.23e-07 | 30 | 117 | 5 | CID000001226 | |
| Drug | GYKI 53655 | 4.23e-07 | 30 | 117 | 5 | CID000126757 | |
| Drug | aurintricarboxylic acid | 4.47e-07 | 91 | 117 | 7 | CID000002259 | |
| Drug | 2-amino-4-phosphonobutyric acid | 4.47e-07 | 91 | 117 | 7 | CID000002207 | |
| Drug | Naspm | 4.57e-07 | 13 | 117 | 4 | CID000129695 | |
| Drug | NPC 12626 | 5.02e-07 | 31 | 117 | 5 | CID000108099 | |
| Drug | LY235959 | 5.02e-07 | 31 | 117 | 5 | CID000131938 | |
| Drug | JNK inhibitor VIII | 5.27e-07 | 4 | 117 | 3 | CID011624601 | |
| Drug | sunifiram | 5.27e-07 | 4 | 117 | 3 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 5.27e-07 | 4 | 117 | 3 | CID011105661 | |
| Drug | 3-isoxazolol | 5.27e-07 | 4 | 117 | 3 | CID009964065 | |
| Drug | MPEP | 5.84e-07 | 59 | 117 | 6 | CID003025961 | |
| Drug | KW-6002 | 5.93e-07 | 32 | 117 | 5 | CID005311037 | |
| Drug | quinoxaline-2,3-dione | 6.37e-07 | 14 | 117 | 4 | CID011469229 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.98e-07 | 16 | 116 | 4 | DOID:331 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.42e-05 | 145 | 116 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | NF-kappa-B essential modulator measurement | 4.58e-05 | 3 | 116 | 2 | EFO_0010597 | |
| Disease | Intellectual Disability | 7.07e-05 | 447 | 116 | 9 | C3714756 | |
| Disease | level of chitinase-3-like protein 1 in blood serum | 9.15e-05 | 4 | 116 | 2 | OBA_2041005 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.52e-04 | 68 | 116 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 1.71e-04 | 295 | 116 | 7 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Schizophrenia | CACNA1B PSAT1 RELN GRIA1 GRIA2 GRIA3 GRIA4 GRIN2D GRM5 LIFR MAPK8 RIMS2 | 1.91e-04 | 883 | 116 | 12 | C0036341 |
| Disease | Psychosexual Disorders | 2.27e-04 | 6 | 116 | 2 | C0033953 | |
| Disease | Hypoactive Sexual Desire Disorder | 2.27e-04 | 6 | 116 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 2.27e-04 | 6 | 116 | 2 | C0036902 | |
| Disease | Frigidity | 2.27e-04 | 6 | 116 | 2 | C0016722 | |
| Disease | Orgasmic Disorder | 2.27e-04 | 6 | 116 | 2 | C0029261 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 3.18e-04 | 7 | 116 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | pulse pressure measurement, diastolic blood pressure, systolic blood pressure, hypertension | 3.53e-04 | 35 | 116 | 3 | EFO_0000537, EFO_0005763, EFO_0006335, EFO_0006336 | |
| Disease | Congenital disorder of glycosylation | 4.52e-04 | 38 | 116 | 3 | cv:C0282577 | |
| Disease | rheumatoid arthritis, Crohn's disease | 4.52e-04 | 38 | 116 | 3 | EFO_0000384, EFO_0000685 | |
| Disease | ankylosing spondylitis | 4.66e-04 | 91 | 116 | 4 | EFO_0003898 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 5.42e-04 | 9 | 116 | 2 | C0085413 | |
| Disease | 2-hydroxystearate measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0021059 | |
| Disease | susceptibility to childhood ear infection measurement | 5.89e-04 | 171 | 116 | 5 | EFO_0007904 | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 6.75e-04 | 10 | 116 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | Myopia | 8.41e-04 | 385 | 116 | 7 | HP_0000545 | |
| Disease | Glioblastoma Multiforme | 9.82e-04 | 111 | 116 | 4 | C1621958 | |
| Disease | psychological resilience measurement | 9.86e-04 | 12 | 116 | 2 | EFO_0009945 | |
| Disease | Trigeminal Neuralgia | 9.86e-04 | 12 | 116 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 9.86e-04 | 12 | 116 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 9.86e-04 | 12 | 116 | 2 | C0393786 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 1.14e-03 | 52 | 116 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | Cocaine-Related Disorders | 1.19e-03 | 117 | 116 | 4 | C0236736 | |
| Disease | lymphocyte measurement | 1.19e-03 | 117 | 116 | 4 | EFO_0803546 | |
| Disease | electrocardiography | 1.20e-03 | 530 | 116 | 8 | EFO_0004327 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.35e-03 | 14 | 116 | 2 | EFO_0022085 | |
| Disease | congenital disorder of glycosylation type I (implicated_via_orthology) | 1.56e-03 | 15 | 116 | 2 | DOID:0050570 (implicated_via_orthology) | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.56e-03 | 15 | 116 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | YKL40 measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0004869 | |
| Disease | Cocaine Abuse | 1.62e-03 | 127 | 116 | 4 | C0009171 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 1.67e-03 | 216 | 116 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | fatty acid measurement | 1.72e-03 | 436 | 116 | 7 | EFO_0005110 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.80e-03 | 61 | 116 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | urolithiasis | 1.98e-03 | 63 | 116 | 3 | MONDO_0024647 | |
| Disease | Cocaine Dependence | 2.25e-03 | 139 | 116 | 4 | C0600427 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.59e-03 | 239 | 116 | 5 | EFO_0010934 | |
| Disease | coronary artery disease | DHX58 FN1 SWAP70 BCAS3 NEK9 STK3 FAP SLC22A1 SCARB1 CABIN1 STK24 TRIB1 | 2.62e-03 | 1194 | 116 | 12 | EFO_0001645 |
| Disease | acetate measurement | 2.78e-03 | 20 | 116 | 2 | EFO_0010112 | |
| Disease | ulcerative colitis, Crohn's disease | 2.78e-03 | 20 | 116 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.79e-03 | 71 | 116 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Bipolar Disorder | 2.84e-03 | 477 | 116 | 7 | C0005586 | |
| Disease | Alzheimer disease | 3.11e-03 | 485 | 116 | 7 | MONDO_0004975 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 3.13e-03 | 74 | 116 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | psoriasis, type 2 diabetes mellitus | 3.25e-03 | 75 | 116 | 3 | EFO_0000676, MONDO_0005148 | |
| Disease | glioma | 3.36e-03 | 22 | 116 | 2 | EFO_0005543 | |
| Disease | Drugs used in diabetes use measurement | 3.41e-03 | 255 | 116 | 5 | EFO_0009924 | |
| Disease | asparaginase hypersensitivity | 3.50e-03 | 77 | 116 | 3 | EFO_0004881 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.53e-03 | 257 | 116 | 5 | DOID:10652 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YHSLLGNDWKTIGEM | 631 | Q15361 | |
| LYGDNVEEMDWLIGK | 321 | P51689 | |
| KSGMYGIRELDQKTW | 61 | A8MTT3 | |
| VGIWGEGKDMYLILE | 461 | Q92870 | |
| EWMLYIQKLLEGQSL | 1361 | Q9NXG0 | |
| WRGQYDVAIKMIKEG | 421 | Q06187 | |
| LVYFNIIIMWDSKSG | 486 | Q9Y672 | |
| WKAYMAEVEGVINGT | 71 | Q92685 | |
| GWYMDKTSIAVLGVA | 206 | Q9H6U8 | |
| LDSWIALYKMQGLCI | 681 | Q8IZP9 | |
| GNYKLLVTMEDWSGR | 361 | Q9UKU9 | |
| TEVLMWFYVGEIIGK | 81 | O75964 | |
| LLIMIGYSDGMQVWS | 91 | Q9H6U6 | |
| NGYLEWIFKAEEVML | 386 | Q00975 | |
| KGLDLEMAIAYWNLV | 171 | Q96GG9 | |
| ADMATGVKCGIIYWL | 46 | Q9NUZ1 | |
| GQILQKLGMWYEAAE | 201 | Q96QP1 | |
| VICAIDYTWMLLKDG | 236 | Q9Y2R2 | |
| EELYVAGNMVIWSKG | 91 | Q9H1A4 | |
| FWKEEMELTLVGLQY | 16 | Q9NVJ2 | |
| FWKEEMELTLVGLQY | 16 | Q96BM9 | |
| YLKQKGLGGAMVWAL | 346 | Q13231 | |
| VILGMGYKENVDIWS | 196 | P45984 | |
| GYKENVDIWSVGCIM | 201 | P45984 | |
| GEILTDMKYGHLWSV | 466 | Q9NPJ1 | |
| LGLQWLEYMDGKATN | 2446 | Q86XX4 | |
| YINVGSWDNGELKMD | 481 | P41594 | |
| TKAEMLGSVVGNWQY | 131 | P43357 | |
| TKAEMLGSVVGNWQY | 131 | P43360 | |
| WEALSVMGVYVGKEH | 221 | P43362 | |
| LGMGYKENVDIWSVG | 236 | P53779 | |
| GKILVWKELDYGSMT | 31 | P51955 | |
| VEKELYTWVNMQGGT | 386 | Q8TD19 | |
| TEITKGWLYGLLMLQ | 276 | Q6UXM1 | |
| DTYLLAGGWMLKMTQ | 2406 | Q8NDA2 | |
| MWGQSLYILGSLMAE | 401 | P46020 | |
| ALYLVEEAWAEAGKM | 106 | F2Z398 | |
| GYLCAMKITEGDLWI | 986 | Q5JUK3 | |
| GVLMQKASLVIQDYW | 1476 | Q8N6G6 | |
| ADTKIWNGMVGELVY | 476 | P42262 | |
| WNGMVGELVYGKADI | 481 | P42262 | |
| ETKIWNGMVGELVYG | 486 | P42263 | |
| IWNGMVGELVYGKAE | 481 | P48058 | |
| VILGMGYKENVDLWS | 196 | P45983 | |
| GYKENVDLWSVGCIM | 201 | P45983 | |
| KGYNRSLDMWSVGVI | 751 | O94806 | |
| MLALGNQVGKLYVWD | 376 | O75530 | |
| VIMAALQTKGYEAVW | 86 | Q15040 | |
| HKYIILGSDGLWNMI | 306 | O15297 | |
| ISLMKGGSKEYWFVL | 531 | P50570 | |
| VGGGWMALDEFLVKN | 7171 | Q9UPN3 | |
| LEYSVNGGITWNLLM | 2596 | P78509 | |
| GKVLQVIVWGDYGRM | 1616 | Q86UR5 | |
| WYLGLDKEGQVMKGN | 171 | Q92914 | |
| KVLQIIVWGDYGRMD | 1336 | Q9UQ26 | |
| MGSWLKVNGEAIYET | 356 | Q9BTY2 | |
| EWVAGKVHLILYMLG | 581 | A2A2Y4 | |
| GDEEEWLIHYMLGKV | 1201 | Q9Y6J0 | |
| VYLDVIDKWGTDDML | 186 | Q92874 | |
| KGIIWGEDTLMEYLE | 56 | P99999 | |
| VLASKDGWVDIMYDG | 1481 | O43497 | |
| YGLAATMIQEGLTWE | 826 | Q9HCG7 | |
| SSDGILYMGKKQDIW | 111 | O75460 | |
| DSGVVYSVGMQWLKT | 311 | P02751 | |
| KYLVWVQAANALGME | 191 | Q5VWK5 | |
| KVLSYVDWIKGVMNG | 471 | Q9NZP8 | |
| MWLLEKAGYKVGAAE | 1 | B7Z1M9 | |
| LGSLAMVIEGLKYIW | 476 | Q7Z388 | |
| GEVWGLQMIYKSVKL | 616 | Q96C10 | |
| LLLGAKEYSTAVDMW | 596 | Q9UQ88 | |
| WLGHKGMVLSAEYIK | 426 | Q9Y4D2 | |
| DMIWIVGGSSVYKEA | 111 | Q86XF0 | |
| SKLGDDIWIIYEQVM | 46 | Q15006 | |
| LLGWYMVKSGLEEKS | 196 | Q7KZN9 | |
| MKDGQLYLTGGVWSL | 271 | P08397 | |
| TKAWNGMVGELVYGR | 471 | P42261 | |
| MAKGLLVTYALWAVG | 1 | Q8N4W6 | |
| LVSKGNWMAGYTLIT | 211 | O15245 | |
| VVGMGKGILLTWHYD | 636 | P42702 | |
| VGDWLDSIKMGQYKN | 966 | Q9UF33 | |
| IYGMRTKQLLEGIWS | 296 | Q8NGK6 | |
| ELWIGLNDIKIQMYF | 421 | P22897 | |
| SELLAVMDGDWTLKY | 461 | Q9P2B2 | |
| WGKILGLEMNYIVAE | 356 | Q5TD94 | |
| QEKMTEIGIRSGWKY | 611 | Q68CJ6 | |
| LAWEAKYLMELGNAL | 311 | Q5TGY1 | |
| MGLCWKEVAYLGNEV | 361 | Q8NFW8 | |
| KLWIIMEYLGGGSAL | 106 | Q9Y6E0 | |
| YQWGIMKSLGLSDEE | 156 | Q9P2J5 | |
| LAMEVGLVLWVKEYD | 96 | P03923 | |
| FSIYVMGLVLEWIKN | 246 | Q9Y617 | |
| DDINKFLWMVRIGGS | 591 | P46977 | |
| VGEIMWGYKDPLVNL | 176 | Q8WTV0 | |
| LSGYVIMWNKAIELS | 176 | Q5T5C0 | |
| LMSGLDYIKNELQTW | 1791 | Q13023 | |
| NWISYLASKEGMVIA | 556 | Q12884 | |
| MGYTITLWDLETQGM | 446 | Q96JI7 | |
| QEIIAGGDVKYTTWM | 431 | A4UGR9 | |
| KNTDLWIVMEYCGAG | 91 | Q13188 | |
| IAEAYAELIKQMWSG | 351 | Q13107 | |
| SGKAADVWSLGVMLY | 261 | Q96RU8 | |
| GQYLVSLIRDKLGWM | 441 | Q8NCC5 | |
| ETWGGYMAAKVQKLE | 16 | Q9UBZ9 | |
| SGKAADVWSLGVMLY | 231 | Q92519 | |
| WETVLGQEMYKLLLF | 476 | Q7Z404 | |
| MNRYLTTGDLDGWLK | 431 | Q8IV35 | |
| VDLEQWYQELMAGLG | 921 | Q86UU1 | |
| KFTEGSLLDGLYWKM | 281 | Q13563 | |
| ADLNIDSWLIKGLMY | 321 | Q8IUH5 | |
| ENWAVVKAALVAGMY | 966 | Q9H6S0 | |
| LQVATFKGWMDIIYA | 1251 | Q9UI33 | |
| YLLKKLTEAMGGGWQ | 141 | Q9UH65 | |
| GGLKAVVWTDAFQMV | 176 | Q1EHB4 | |
| EYKIMVAALGWATAE | 96 | Q9BVK8 | |
| ASMWDGLGEEQKQVY | 296 | O94900 | |
| VAEEFGIIMKALWTG | 826 | P40818 | |
| MAKCYGDLVQELWSG | 581 | P35125 | |
| GEIKQMWDGGLQDYI | 416 | Q9UBN4 | |
| KTALLEGLEVDQYMW | 786 | Q9ULJ6 | |
| DNLYKSDLEWMKGIG | 3381 | P20929 | |
| KIDGVWNGMIGEVFY | 516 | O15399 |